Evidence map›Paper›PMID 35326871›Full record

ArticleAntibiotics (Basel, Switzerland)2022

Incidence of Vancomycin-Resistant

Samy Selim, Osama Ahmed Faried, Mohammed S Almuhayawi, Fayez M Saleh, Mohamed Sharaf, Nihal El Nahhas, Mona Warrad

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
3.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it, 34 citations in OpenAlex.

  1. Global prevalence of macrolide-resistantFrontiers in microbiology · 2025
    Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Detection of biofilm genes in MDROpen veterinary journal · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Antibiotic Resistance in Bacterial Pathogens.Antibiotics (Basel, Switzerland) · 2023
    Article
  11. Article
  12. Biogenic silver nanoparticles eradicate ofFrontiers in microbiology · 2023
    Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 3 countries.

Samy SelimDepartment of Clinical Laboratory Sciences, College of Applied Medical Sciences, Jouf University, Sakaka 72341, Saudi Arabia.ORCID 0000-0003-4025-8586
Osama Ahmed FariedMedical Microbiology and Immunology Department, Faculty of Medicine, Beni-Suef University, Beni-Suef 62513, Egypt.
Mohammed S AlmuhayawiDepartment of Medical Microbiology and Parasitology, Faculty of Medicine, King Abdulaziz University, Jeddah 21589, Saudi Arabia.
Fayez M SalehDepartment of Medical Microbiology, Faculty of Medicine, University of Tabuk, Tabuk 71491, Saudi Arabia.ORCID 0000-0001-8417-8874
Mohamed SharafDepartment of Biochemistry, Faculty of Agriculture, AL-Azhar University, Cairo 11651, Egypt.ORCID 0000-0002-5891-7378
Nihal El NahhasDepartment of Botany and Microbiology, Faculty of Science, Alexandria University, Alexandria 21526, Egypt.ORCID 0000-0003-2717-9250
Mona WarradDepartment of Clinical Laboratory Sciences, College of Applied Medical Sciences at Al-Quriat, Jouf University, Al-Quriat 77454, Saudi Arabia.
Al-Azhar University · EGAlexandria University · EGBeni-Suef University · EGJouf University · SAKing Abdulaziz University · SAUniversity of Tabuk · SA

Funding

Al Jouf University DSR-2021-01-0346
6 · The paper itself

Abstract

There has been a substantial rise in the number of vancomycin-resistant

Indexed as

genotypingplasmidSaudi ArabiaStaphylococcus aureusurinary tract infectionsvancomycin resistanceVRSA

Identifiers

PMID35326871
PMCPMC8944512
OpenAlexW4220996102

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.